Hasnain Faheem
SEC insider (Form 3/4/5 filer). CIK 0001352620. Executive Chair at Aspen Neuroscience, Inc. (ASPE) and 2 other issuers. 31 reported Form 4/5 transactions since Sep 2024; latest on Aug 24, 2026. Located in SAN DIEGO, CA.
Companies Hasnain Faheem has filed insider reports for
- Aspen Neuroscience, Inc. (ASPE): Director, Officer, Executive Chair
- Gossamer Bio, Inc. (GOSS): Director, Officer, President & CEO
- Kura Oncology, Inc. (KURA): Director
Hasnain Faheem
CIK: 0001352620
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (31 total)
- Aug 24, 2026GOSS
Gossamer Bio, Inc.
AwardIndirectPre-Funded Warrant (Right to Buy)
166 shares at avg. $1000.00- - Aug 24, 2026GOSS
Gossamer Bio, Inc.
AwardDirectStock Option (Right to Buy)
5.8M shares- - Jun 4, 2026KURA
Kura Oncology, Inc.
AwardDirectOption to purchase common stock
35K shares- - Mar 19, 2026GOSS
Gossamer Bio, Inc.
DispositionDirectStock Option (Right to Buy)
544.5K shares- - Mar 19, 2026GOSS
Gossamer Bio, Inc.
DispositionDirectStock Option (Right to Buy)
1.3M shares- - Mar 19, 2026GOSS
Gossamer Bio, Inc.
DispositionDirectStock Option (Right to Buy)
1.5M shares- - Mar 19, 2026GOSS
Gossamer Bio, Inc.
DispositionDirectStock Option (Right to Buy)
437.5K shares- - Mar 19, 2026GOSS
Gossamer Bio, Inc.
DispositionDirectStock Option (Right to Buy)
544.5K shares- - Mar 19, 2026GOSS
Gossamer Bio, Inc.
DispositionDirectStock Option (Right to Buy)
1.7M shares- - Mar 19, 2026GOSS
Gossamer Bio, Inc.
DispositionDirectStock Option (Right to Buy)
650K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 24, 2026 |  GOSS Gossamer Bio, Inc. | Award Pre-Funded Warrant (Right to Buy) | 166 | $1000.00 | - | Indirect |
| Aug 24, 2026 | GOSS Gossamer Bio, Inc. | Award Stock Option (Right to Buy) | 5,800,051 | - | - | Direct |
| Jun 4, 2026 |  KURA Kura Oncology, Inc. | Award Option to purchase common stock | 35,000 | - | - | Direct |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | Disposition Stock Option (Right to Buy) | 544,500 | - | - | Direct |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | Disposition Stock Option (Right to Buy) | 1,312,500 | - | - | Direct |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | Disposition Stock Option (Right to Buy) | 1,540,000 | - | - | Direct |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | Disposition Stock Option (Right to Buy) | 437,500 | - | - | Direct |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | Disposition Stock Option (Right to Buy) | 544,500 | - | - | Direct |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | Disposition Stock Option (Right to Buy) | 1,680,000 | - | - | Direct |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | Disposition Stock Option (Right to Buy) | 650,000 | - | - | Direct |
1-10 of 31 transactions